Scotia Capital Inc. Editas Medicine, Inc. Transaction History

Scotia Capital Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$26.55 - $40.57 $678,166 - $1.04 Million	-25,543 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$39.27 - $72.94 $30,159 - $56,017	768 Added 3.1%	25,543 $1.05 Million
Q2 2021 Aug 12, 2021	BUY	$31.29 - $56.64 $25,501 - $46,161	815 Added 3.4%	24,775 $1.4 Million
Q1 2021 May 06, 2021	BUY	$39.71 - $90.58 $951,451 - $2.17 Million	23,960 New	23,960 $1.01 Million

225

54.2M

412K

355K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $132M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Scotia Capital Inc. with notifications on news.